Friday, June 15, 2007 9:34:25 AM
J&J's Cordis unit resolves issues with FDA
CHICAGO, June 14 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile , Research) on Thursday said its Cordis unit, which makes cardiovascular devices, has resolved its issues with the U.S. Food and Drug Administration, clearing the way for the introduction of new products.
Cordis, best known for its Cypher drug-eluting heart stent, has been operating under a warning from the FDA since April 2004. Regulators cited problems with internal procedures, including many issues with manufacturing processes.
Resolving the issues with the FDA means the company can now launch the next-generation of its Cypher stent, a tiny, tubular device that props open diseased arteries and delivers drugs to the site to prevent the vessels from reclogging.
Cordis' Cypher stent competes in the United States with Boston Scientific's (BSX.N: Quote, Profile , Research) Taxus drug-eluting stent. Medtronic Inc. (MDT.N: Quote, Profile , Research) and Abbott Laboratories (ABT.N: Quote, Profile , Research) are expected to launch similar products in the United States over the next few years.
However, the use of such devices, initially hailed as revolutionary, has declined over the last few quarters amid controversy that they may pose serious risks of deadly blood clots.
And drug-eluting stents, which have been lucrative for the manufacturers, came under fire when a study suggested the devices were no better than standard drug treatments in reducing deaths and heart attacks in patients with minor chest pain.
Miami Lakes, Florida-based Cordis said the penetration of drug-eluting stents, also known as drug-coated stents, was down to the mid-60 percent range as of April from a peak in the mid-80 percent range a few years ago.
J&J shares were up 9 cents to $62.27 while shares of competitor Boston Scientific were up 2 cents to $16.16 in early the New York Stock Exchange trade.
Recent SOTK News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/23/2024 06:05:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 11:21:13 AM
- Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog • GlobeNewswire Inc. • 05/23/2024 11:00:00 AM
- Sono-Tek Announces Year-End FY 2024 Earnings Conference Call • GlobeNewswire Inc. • 05/20/2024 11:00:00 AM
- Sono-Tek Announces Preliminary Net Sales for Q4 and FY2024 and Provides Preliminary Sales Guidance for Q1 FY2025 and FY2025 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Sono-Tek to Present at The LD Micro Invitational XIV • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 08:09:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:09:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 04:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:25:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:18:20 PM
- Sono-Tek Announces Appointment of Randy A. Copeman to Chief Technologist • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:39:22 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/31/2024 03:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:28:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:21:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:36:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:29:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:58:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/18/2024 04:01:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 02:07:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:10:47 PM
- Sono-Tek Reports 59% Increase in Q3 Fiscal 2024 Net Sales to Record $5.7 Million and Provides Sales Guidance for Fiscal Year 2024 • GlobeNewswire Inc. • 01/16/2024 01:00:51 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM